COMMUNIQUÉS West-GlobeNewswire

Lancement d’un fonds de secours en réponse à l’ouragan Béryl
03/07/2024
OTTAWA, 03 juill. 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a mis sur pied le Fonds de secours : Ouragan Béryl afin de venir en aide aux personnes touchées par la catastrophe. La Croix-Rouge s’emploie à [...]
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
03/07/2024
Sheridan, Wyoming, USA, July 03, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a joint industrial [...]
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
03/07/2024
Multiple studies confirm ART12.11’s superior advantages as a product candidate for the treatment of anxiety related disorders SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
03/07/2024
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses preliminary positive results from the first five “lead-in” patients in the Company’s ongoing human clinical trial THE WOODLANDS, TX , July 03, 2024 ( [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
03/07/2024
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]
The International Myeloma Foundation Thanks Dr. Brian G.M. Durie for 35 Years of Remarkable Leadership
03/07/2024
Assembles Global Dream Team and Establishes Scientific Advisory Board to Accelerate Myeloma Research STUDIO CITY, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that [...]
McGill, industry, CQDM and Brain Canada collaborate for drug discovery
03/07/2024
Novel drug could provide hope to those suffering from neuropathic pain and insomnia MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- A diverse consortium, combining expertise from McGill University, the Quebec government and [...]
McGill, l’industrie, le CQDM et la Fondation Brain Canada collaborent à la mise au point d’un nouveau médicament pour traiter l'insomnie et la douleur
03/07/2024
Un nouveau médicament prometteur donne de l’espoir aux personnes aux prises avec des douleurs neuropathiques et l’insomnie MONTRÉAL, 03 juill. 2024 (GLOBE NEWSWIRE) -- Un groupe diversifié réunissant les expertises de l [...]
SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device
03/07/2024
DENVER, July 03, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
03/07/2024
Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial BRAINTREE, Mass., July 03, 2024 (GLOBE NEWSWIRE) -- [...]
Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
03/07/2024
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
03/07/2024
DALLAS, July 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
The Canadian Dermatology Association Announces 2024 Award Recipients
03/07/2024
OTTAWA, Ontario, July 03, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is proud to announce this year’s recipients of its Member Awards and Public Education Awards, following a detailed review of [...]
L’Association canadienne de dermatologie annonce les lauréats de ses prix de 2024
03/07/2024
OTTAWA, Ontario, 03 juill. 2024 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) est ravie d’annoncer les lauréats des Prix des membres et des Prix d’éducation publique de cette année. Le Comité des [...]
BC Platforms Announces Appointment of New Chairman, Alex Dickinson
03/07/2024
Serial entrepreneur and precision medicine technologist to drive strategic agenda at BC Platforms ZURICH, July 03, 2024 (GLOBE NEWSWIRE) -- BC Platforms, a global leader in real world data, healthcare data management, [...]
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results
03/07/2024
Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage [...]
Apollomics Announces Updated Strategic Focus and Leadership Team Changes
03/07/2024
Focus on vebreltinib study enrollment for non-small cell lung cancer (NSCLC) patients with Met Amplification mutations targets greatest unmet medical need FOSTER CITY, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- [...]
IntelGenx Obtains Preliminary Efficacy Results for the ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
03/07/2024
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease ( [...]
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
03/07/2024
UPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, introduces its inaugural network of Olink ® Certified Service Providers. The group of Olink [...]

Pages